The recognition of OS-CSCs and their environment facilitated advances in 3D tissue-engineered models, because it better recreates the native tumor and will activate critical pathways, including MAPK, PI3K, and TGF-β/SMAD pivotal to the pathogenesis of osteosarcoma [52,53]. The gene discussed is TGFB1; the disease is neoplasm.